ATP5MK and neuroblastoma: AGP application in combination with cisplatin or doxorubicin increases the cancer cell-specific cytotoxicity in neuroblastoma (Sukumari-Ramesh et al., 2011), which strengthen the role of AGP as an anticancer immune-modulator.